A new study links changes in the gene for the protein focal adhesion kinase, or FAK, to ovarian cancer’s ability to survive chemotherapy.
A new study links changes in the gene for the protein focal adhesion kinase, or FAK, to ovarian cancer’s ability to survive chemotherapy.